company logo

Principal Biostatistician at MorphoSys AG in Boston, MA

Save

compensation:

$80K — $100K *

specialty:

Life Sciences

experience:

5 - 7 years

Job Description

To advance the development of Tafasitamab and in preparation for its planned commercialization MorphoSys founded MorphoSys US Inc., a wholly owned subsidiary of MorphoSys AG, and raised independent funding by successfully closing an IPO on the Nasdaq U.S. stock exchange in April 2018. Our focused, controlled growth and commercialization journey has been substantial starting in 2018 with our US IPO and culminating in our Incyte Corporation partnership in 2020. These three years have been important for MorphoSys as we continue to strive to deliver innovative medicines to patients who need them. The company is realizing our goal of becoming a fully integrated global biopharmaceutical company.

Tafasitamab is an investigational, Fc-engineered therapeutic antibody targeting CD19 that is in development for the treatment of B cell malignancies. The focus of the development program is on relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), a particularly aggressi

See More

Valid through: 7/16/2020

About MorphoSys AG

Total Jobs:
18
Average Pay:
$149,250
Total value of jobs:
$2,985,000
% Masters:
100%
Learn More About MorphoSys AG
* Ladders Estimates

More Jobs at MorphoSys AG

Similar Jobs

More Pharmaceuticals & Biotech Jobs

Senior Process Engineer - Skin Substitute Therapeutics

$180K — $225K + $120 hourly

Confidential Company

Boston, MA 02110

Today

Sales Manager-Chain Drug

$130K — $150K + $13K—$15K bonus + 15% company paid ira, full medical for family

Yesterday

Environmental Health & Safety Manager

$80K — $90K

Confidential Company

Waterloo, IA 50704

3 days ago

Find similar Biostatistician jobs: